Stalicla

Healthcare · 2017 · Switzerland

Stalicla is a global, clinical-stage biotechnology company focused on advancing precision medicine for brain diseases founded in 2017.

STALICLA’s unique approach addresses a principal weakness in the drug development process for NDD’s and neuropsychiatric disorders: behavior is a terriblebiomarker.

Clinical psychiatric and neurodevelopmental diagnoses encompass a broad diversity of underlying biology. This has contributed to drug development failure by diluting true responders in a population of patients with heterogeneous biology.

le site

with one conviction:
together, anything is possible

send us your deck

stay in touch